Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrey A Ivashchenko

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Current Drug Discovery Technologies|February 14, 2006
Efficient optimization strategy for marginal hits active against abl tyrosine kinasesSergey E Tkachenko, Ilya Okun, Konstantin V Balakin, et al.
Journal of Chemical Information and Computer Sciences|May 28, 2003
Advanced exact structure searching in large databases of chemical compoundsSergey V Trepalin, Andrey V Skorenko, Konstantin V Balakin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 23, 2004
Quantitative structure-metabolism relationship modeling of metabolic N-dealkylation reaction ratesKonstantin V Balakin, Sean Ekins, Andrey Bugrim, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 3, 2004
Kohonen maps for prediction of binding to human cytochrome P450 3A4Konstantin V Balakin, Sean Ekins, Andrey Bugrim, et al.
Molecules (Basel, Switzerland)|August 12, 2022
The Efficacy of Aprotinin Combinations with Selected Antiviral Drugs in Mouse Models of Influenza Pneumonia and Coronavirus Infection Caused by SARS-CoV-2Andrey A Ivashchenko, Bogdan A Zagribelnyy, Yan A Ivanenkov, et al.
European Journal of Medicinal Chemistry|January 24, 2020
Synthesis, biological evaluation and in silico modeling of novel integrase strand transfer inhibitors (INSTIs)Andrey A Ivashchenko, Yan A Ivanenkov, Angela G Koryakova, et al.
Biochemical and Biophysical Research Communications|September 9, 2024
Liposome-encapsulated aprotinin biodistribution in mice: Side-by-side comparison with free drug formulationElizaveta N Mochalova, Vladimir R Cherkasov, Artem A Sizikov, et al.
Bioorganic & Medicinal Chemistry|October 17, 2020
Synthesis, biological evaluation and in silico modeling of novel pan-genotypic NS5A inhibitorsAndrey A Ivashchenko, Yan A Ivanenkov, Vladimir A Aladinskiy, et al.
Viruses|July 2, 2021
Effect of Aprotinin and Avifavir<sup>®</sup> Combination Therapy for Moderate COVID-19 PatientsAndrey A Ivashchenko, Valeria N Azarova, Alina N Egorova, et al.
Journal of Psychiatric Research|October 17, 2021
Safety and efficacy of aviandr in patients with generalized anxiety disorder: A multicenter, randomized, double-blind, placebo-controlled, dose-finding, pilot studyAndrey A Ivashchenko, Margarita A Morozova, Natalia V Vostokova, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Current Drug Discovery Technologies|February 14, 2006
Efficient optimization strategy for marginal hits active against abl tyrosine kinasesSergey E Tkachenko, Ilya Okun, Konstantin V Balakin, et al.
Journal of Chemical Information and Computer Sciences|May 28, 2003
Advanced exact structure searching in large databases of chemical compoundsSergey V Trepalin, Andrey V Skorenko, Konstantin V Balakin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 23, 2004
Quantitative structure-metabolism relationship modeling of metabolic N-dealkylation reaction ratesKonstantin V Balakin, Sean Ekins, Andrey Bugrim, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 3, 2004
Kohonen maps for prediction of binding to human cytochrome P450 3A4Konstantin V Balakin, Sean Ekins, Andrey Bugrim, et al.
Molecules (Basel, Switzerland)|August 12, 2022
The Efficacy of Aprotinin Combinations with Selected Antiviral Drugs in Mouse Models of Influenza Pneumonia and Coronavirus Infection Caused by SARS-CoV-2Andrey A Ivashchenko, Bogdan A Zagribelnyy, Yan A Ivanenkov, et al.
European Journal of Medicinal Chemistry|January 24, 2020
Synthesis, biological evaluation and in silico modeling of novel integrase strand transfer inhibitors (INSTIs)Andrey A Ivashchenko, Yan A Ivanenkov, Angela G Koryakova, et al.
Biochemical and Biophysical Research Communications|September 9, 2024
Liposome-encapsulated aprotinin biodistribution in mice: Side-by-side comparison with free drug formulationElizaveta N Mochalova, Vladimir R Cherkasov, Artem A Sizikov, et al.
Bioorganic & Medicinal Chemistry|October 17, 2020
Synthesis, biological evaluation and in silico modeling of novel pan-genotypic NS5A inhibitorsAndrey A Ivashchenko, Yan A Ivanenkov, Vladimir A Aladinskiy, et al.
Viruses|July 2, 2021
Effect of Aprotinin and Avifavir<sup>®</sup> Combination Therapy for Moderate COVID-19 PatientsAndrey A Ivashchenko, Valeria N Azarova, Alina N Egorova, et al.
Journal of Psychiatric Research|October 17, 2021
Safety and efficacy of aviandr in patients with generalized anxiety disorder: A multicenter, randomized, double-blind, placebo-controlled, dose-finding, pilot studyAndrey A Ivashchenko, Margarita A Morozova, Natalia V Vostokova, et al.
Pageof 3